Join us in supporting The Leukemia & Lymphoma Society at
Play for a Cause:
A Songwriter's Round to End Blood Cancer
Corsair Distillery in Marathon Village
Play for a Cause will feature nine local, up-and-coming artists along with a surprise artist to play the song "Light The Night," originally performed by Charles Esten and written by Gene Rapisardi. Attendees will see three sets with three artists in each set. Each artist will give a short story about what led them to write their original song before an intimate acoustic performance.
To purchase tickets, please click "Buy Tickets" on the top left.
If you'd like to make an additional donation to The Leukemia & Lymphoma Society, please do so through NextGen Nashville's fundraising page here.
With Performances By:
My One and Only
With your support, The Leukemia & Lymphoma Society will continue to fund groundbreaking research and ensure patients have access to treatment. LLS has three major pillars: research, patient access and policy advocacy.
Since 2017, there have been a record-setting 47 blood cancer treatments approved by the FDA; LLS helped fund and develop 41 of them. Our work extends far beyond blood cancer, as LLS-funded research has led to the discoveries of treatments for several other cancers and diseases.
Patient Access to Care & Education
LLS has allocated over $2.3 million to Tennessee residents in the past year alone. This money helps cancer patients cover the cost of treatments, co-payments and travel. On top of patient access to life-saving healthcare, LLS is also the leading source of free educational materials and support groups. We also offer free one-on-one consultations regarding patients' treatment and financial options.
LLS fights on behalf of cancer patients at both state and federal levels of government. We advocate for policies to ensure that all patients have access to affordable, top-of-the-line care.
We appreciate your support and would love to have you attend Nashville's Light The Night, LLS' largest event of the year. You can learn more about it here.